RecruitingPhase 2NCT07325253
A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Graft Versus Host Disease Manifestations
Sponsor
M.D. Anderson Cancer Center
Enrollment
16 participants
Start Date
Nov 18, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
To study the safety and possible side effects of using the imaging agent 4-\[18F\]Fluoro-1-Naphthol (also called \[18F\]4FN) in PET/CT scans for participants with chronic GVHD.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying PET-CT and a drug called [18F]-4FN for people with host disease manifestation, pet/ct imaging, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUG[18F]-4FN
Given by IV
OTHERPET-CT
Imaging
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07325253
Related Trials
Early Pregnancy Lifestyle and Glucose Patterns: A Substudy of TOFFFY
NCT07534670
Two Post-Operative Pain Protocols at Discharge for Orthopaedic Patients
NCT072655571 location
PROtective Ventilation With FLOW-Controlled Ventilation
NCT067038143 locations
Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease
NCT069784391 location
Feasibility and Acceptability of Group Medical Visits for Anxiety and Depression
NCT066518011 location